Sugi Predict

Sugi Predict / Compounds / SCHEMBL3266289

SCHEMBL3266289

SCHEMBL3266289

Nc1ccn([C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H]2O)c(=O)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.64
▸ THRB P10828 1/20 0.64
▸ MTOR P42345 1/20 0.64
▸ MDM2 Q00987 1/20 0.64
▸ NCOA1 Q15788 1/20 0.64
▸ NCOA3 Q9Y6Q9 1/20 0.64
▸ NT5E P21589 1/20 0.53
▸ PDE4D Q08499 1/20 0.48
▸ PDE3A Q14432 1/20 0.48
▸ SLC29A1 Q99808 1/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ AHCY P23526 1/20 0.48
▸ TMEM97 Q5BJF2 1/20 0.48
▸ SIGMAR1 Q99720 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ HASPIN Q8TF76 1/20 0.46
▸ ST6GAL1 P15907 1/20 0.46
▸ TSHR P16473 1/20 0.45
▸ GLA P06280 1/20 0.45
▸ P2RY2 P41231 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL27920682 0.95 LMNA (0.59) LMNATHRBMTORMDM2NCOA1
SCHEMBL27267985 0.88 LMNA (0.60) LMNATHRBMTORMDM2NCOA1
SCHEMBL1981224 0.88 LMNA (0.63) LMNATHRBMTORMDM2NCOA1
SCHEMBL3662232 0.87 LMNA (0.59) LMNATHRBMTORMDM2NCOA1
SCHEMBL3662233 0.87 LMNA (0.59) LMNATHRBMTORMDM2NCOA1
SCHEMBL3867213 0.87 LMNA (0.59) LMNATHRBMTORMDM2NCOA1
Hydrochloric Acid SCHEMBL6946856 0.87 LMNA (0.62) LMNATHRBMTORMDM2NCOA1
SCHEMBL5154901 0.87 LMNA (0.62) LMNATHRBMTORMDM2NCOA1
Water SCHEMBL9027853 0.86 LMNA (0.58) LMNATHRBMTORMDM2NCOA1
Water SCHEMBL9027861 0.86 LMNA (0.58) LMNATHRBMTORMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079802-A Cationic lipids and compositions thereof — 2026-05-26 — — CN disclosed
US-20250249123-A1 LIPIDS AND COMPOSITIONS THEREOF GENERATION BIO CO. 2025-08-07 — — US disclosed
US-12263228-B2 Lipids and compositions thereof GENERATION BIO CO. (US) 2025-04-01 — — US disclosed
US-20240293574-A1 CATIONIC LIPIDS AND COMPOSITIONS THEREOF GENERATION BIO CO. 2024-09-05 — — US disclosed
US-20240285796-A1 CATIONIC LIPIDS AND COMPOSITIONS THEREOF GENERATION BIO CO. 2024-08-29 — — US disclosed
US-20240226325-A1 CATIONIC LIPIDS AND COMPOSITIONS THEREOF GENERATION BIO CO. 2024-07-11 — — US disclosed
US-11981702-B2 Compounds for fluorescence sensing of duplex formation SAN DIEGO STATE UNIVERSITY (SDSU) FOUNDATION (US) 2024-05-14 — — US disclosed
EP-4355727-A1 CATIONIC LIPIDS AND COMPOSITIONS THEREOF Generation Bio Co. (US) 2024-04-24 — — EP disclosed
CN-117881403-A Thionucleosides as antiviral agents 爱莫里大学 2024-04-12 — — CN disclosed
CN-117642380-A Cationic lipids and compositions thereof 世代生物公司 2024-03-01 — — CN disclosed
WO-2009077671-A1 SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2009-06-25 — — WO disclosed
WO-2008124706-A9 DEVICES AND METHODS FOR TARGET MOLECULE CHARACTERIZATION UNIV ARIZONA STATE (US) 2009-05-28 — — WO disclosed
EP-2059809-A1 MEANS AND METHOD FOR DIAGNOSING HEMOLYTIC ANEMIA Metanomics GmbH (DE) 2009-05-20 — — EP disclosed
WO-2008124706-A2 DEVICES AND METHODS FOR TARGET MOLECULE CHARACTERIZATION ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2008-10-16 — — WO disclosed
WO-2008025579-A1 MEANS AND METHOD FOR DIAGNOSING HEMOLYTIC ANEMIA METANOMICS GMBH (DE) 2008-03-06 — — WO disclosed
WO-2005033332-A2 METHOD FOR THE METHYLATION ANALYSIS OF DNA EPIGENOMICS AG (DE) 2005-04-14 — — WO disclosed
EP-0755260-A1 PHYTOTHERAPEUTIC AGENT FOR TREATMENT OF SKIN LESIONS AND MORBID CHANGES IN THE SKIN AND METHOD FOR ITS PREPARATION Hendricks, Horst Walter (DE) 1997-01-29 — — EP disclosed
EP-0706530-A1 LIPONUCLEOTIDES OF DESOXYNUCLEOSIDES, THEIR PREAPARATION AND THEIR USE AS ANTI-VIRAL DRUGS Roche Diagnostics GmbH (DE) 1996-04-17 — — EP disclosed
WO-1995032723-A1 PHYTOTHERAPEUTIC AGENT FOR TREATMENT OF SKIN LESIONS AND MORBID CHANGES IN THE SKIN AND METHOD FOR ITS PREPARATION HENDRICKS HORST WALTER (DE) 1995-12-07 — — WO disclosed
WO-1995001362-A1 LIPONUCLEOTIDES OF DESOXYNUCLEOSIDES, THEIR PREAPARATION AND THEIR USE AS ANTI-VIRAL DRUGS BOEHRINGER MANNHEIM GMBH (DE) 1995-01-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240226325-A1 CATIONIC LIPIDS AND COMPOSITIONS THEREOF C1R, LRBA, LIPG LMNA 26/4885THRB 1118/4885MTOR 4591/4885
US-12263228-B2 Lipids and compositions thereof C1R, LIPG, LRBA LMNA 49/4885THRB 1569/4885MTOR 4655/4885
US-20250249123-A1 LIPIDS AND COMPOSITIONS THEREOF C1R, LIPG, LRBA LMNA 49/4885THRB 1569/4885MTOR 4655/4885
US-11981702-B2 Compounds for fluorescence sensing of duplex formation ADAR, DCTD, DNTT LMNA 1684/4885THRB 1945/4885MTOR 3726/4885
US-20240293574-A1 CATIONIC LIPIDS AND COMPOSITIONS THEREOF LIPG, LRBA, PCNP LMNA 27/4885THRB 1245/4885MTOR 4267/4885
US-20240285796-A1 CATIONIC LIPIDS AND COMPOSITIONS THEREOF C1R, LRBA, LIPG LMNA 32/4885THRB 1233/4885MTOR 4608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.